Sciarra Alessandro, Maggi Martina, Del Proposto Arianna, Magliocca Fabio Massimo, Ciardi Antonio, Panebianco Valeria, De Berardinis Ettore, Salciccia Stefano, Di Pierro Giovanni Battista, Gentilucci Alessandro, Kasman Alex M, Chung Benjamin I, Ferro Matteo, de Cobelli Ottavio, Del Giudice Francesco, Busetto Gian Maria, Gallucci Michele, Frisenda Marco
Department of Maternal-Infant and Urological Sciences, "Sapienza" Rome University, Policlinico Umberto I Hospital, Rome, Italy.
Department of Radiological, Oncological and Anatomopathological Sciences, "Sapienza" Rome University, Policlinico Umberto I Hospital, Rome, Italy.
Transl Androl Urol. 2021 Jan;10(1):66-76. doi: 10.21037/tau-20-850.
Aim of this study was to correlate perineural invasion (PNI) with other clinical-pathological parameters in terms of prognostic indicators in prostate cancer (PC) cases at the time of radical prostatectomy (RP).
Prospective study of 288 consecutive PC cases undergoing RP. PNI determination was performed either in biopsy or in RP specimens classifying as uni- and multifocal PNI. The median follow-up time was 22 (range, 6-36) months.
At biopsy PNI was found in 34 (11.8%) cases and in 202 (70.1%) cases at the time of surgery. Among those identified at RP 133 (46.1%) and 69 (23.9%) cases had uni- and multi-PNI, respectively. Presence of PNI was significantly (P<0.05) correlated with unfavorable pathological parameters such higher stage and grade. The percentage of extracapsular extension in PNI negative RP specimens was 18.6% 60.4% of PNI positive specimens. However, the distribution of pathological staging and International Society of Urological Pathology (ISUP) grading did not vary according to whether PNI was uni- or multifocal. The risk of biochemical progression increased 2.3 times in PNI positive cases was significantly associated with the risk of biochemical progression (r=0.136; P=0.04). However, at multivariate analysis PNI was not significantly associated with biochemical progression [hazard ratio (HR): 1.87, 95% confidence interval (CI): 0.68-3.12; P=0.089]. Within patients with intermediate risk disease, multifocal PNI was able to predict cases with lower mean time to biochemical and progression free survival (chi-square 5.95; P=0.04).
PNI at biopsy is not a good predictor of the PNI incidence at the time of RP. PNI detection in surgical specimens may help stratify intermediate risk cases for the risk of biochemical progression.
本研究的目的是在前列腺癌(PC)患者行根治性前列腺切除术(RP)时,将神经周围浸润(PNI)与其他临床病理参数作为预后指标进行相关性分析。
对288例连续接受RP的PC病例进行前瞻性研究。PNI的测定在活检或RP标本中进行,分为单灶性和多灶性PNI。中位随访时间为22(范围6 - 36)个月。
活检时发现34例(11.8%)存在PNI,手术时发现202例(70.1%)存在PNI。在RP时确诊的病例中,分别有133例(46.1%)和69例(23.9%)为单灶性和多灶性PNI。PNI的存在与不良病理参数如更高的分期和分级显著相关(P<0.05)。PNI阴性的RP标本中包膜外侵犯的比例为18.6%,PNI阳性标本中为60.4%。然而,病理分期和国际泌尿病理学会(ISUP)分级的分布并未因PNI是单灶性还是多灶性而有所不同。PNI阳性病例生化进展风险增加2.3倍,与生化进展风险显著相关(r = 0.136;P = 0.04)。然而,多因素分析显示PNI与生化进展无显著相关性[风险比(HR):1.87,95%置信区间(CI):0.68 - 3.12;P = 0.089]。在中危疾病患者中,多灶性PNI能够预测生化进展和无进展生存平均时间较短的病例(卡方检验5.95;P = 0.04)。
活检时的PNI并非RP时PNI发生率的良好预测指标。手术标本中PNI的检测可能有助于对中危病例的生化进展风险进行分层。